We earn commissions from the providers listed here. No provider buys a position, a rating, or a listing. The order is set by hand, and we do not claim it is independent of what we earn. Advertising Disclosure
Ivim Health Review: Pricing, Plans, and What to Expect
Personalized Health & Wellness Programs
Ivím Health is a telehealth platform founded in 2021 and based in Columbus, OH, offering GLP-1 weight loss programs and Women's Health Optimization including Hormone Replacement Therapy. Operating in all 50 U.S. states, Ivím Health uses a proprietary GLP-1 ID precision dosing system with weekly dose adjustments. The platform offers unlimited provider visits, wellness coaching, and community support through a membership-based model ($74.99/month plus medication costs).
TL;DR: iVIM Health offers some of the lowest GLP-1 prices in telehealth - compounded semaglutide from $149/month and tirzepatide from $199/month with licensed provider oversight included at those price points. For weight loss patients who have already decided to pursue GLP-1 therapy and are comparing monthly costs across platforms, iVIM is consistently one of the lowest available. Best for cost-sensitive patients who have already qualified or expect to qualify for GLP-1 treatment.
Our Verdict
iVIM Health executes its core value proposition well: competitive compounded GLP-1 pricing with adequate clinical oversight. For patients whose priority is access to semaglutide or tirzepatide at the lowest defensible cost with a licensed provider reviewing their intake and checking in monthly, iVIM delivers that efficiently.
The platform is not for patients who want the most intensive clinical support, behavioral coaching, or integrated lab monitoring. But for cost-conscious patients who meet the eligibility criteria, are comfortable with the medication logistics, and want straightforward access at a price that makes long-term treatment financially realistic, iVIM is a legitimate option in the increasingly competitive GLP-1 telehealth market.
Medical Disclaimer: Content is for informational purposes only - not medical advice. Consult a licensed healthcare provider before any treatment. Learn more
Ivim Health Treatments & Pricing
GLP-1 Weight Loss Program
Ivím Health offers compounded semaglutide (starting $75/month) and tirzepatide (starting $149/month), plus brand-name options. The program uses their proprietary GLP-1 ID precision dosing system with weekly adjustments based on individual response. Membership ($74.99/month) includes unlimited provider visits, coaching, and community support.
Compounded semaglutide injections
Compounded tirzepatide injections
Brand-name options available (Zepbound, Mounjaro, Ozempic, Wegovy)
Ivím Health offers Hormone Replacement Therapy (HRT) for menopause and hormonal transitions at $199/month with a 4-month minimum commitment. The program includes physician consultations, personalized bioidentical hormone therapy protocols, ongoing monitoring, and home medication delivery.
Individual results may vary. Results depend on many factors including adherence to treatment, individual health conditions, and other medications. The information above represents typical ranges based on clinical studies and manufacturer data, not guaranteed outcomes.
Money-Saving Tips for Ivim Health
Here's what you can actually do to lower your Ivim Health cost, based on what they publish about pricing and payment options.
HSA/FSA Eligibility
Ivim Health accepts HSA and FSA payment, so you may be able to put pre-tax money toward eligible treatments. Whether a specific treatment qualifies depends on your plan and IRS rules, so check with your plan administrator before you count on it.
How Ivim Health Works
1Complete online health assessment covering medical history and goals
2Get matched with a licensed provider in your state
3Receive personalized treatment plan with prescription
4Medication delivered to your home
5Begin treatment with weekly dose adjustments (weight loss program)
6Access unlimited provider visits, coaching, and community support
About This Comparison
Our Editorial Standards
This ivim health provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, and service areas. Our ratings are editorial judgments, not tallies of reviews.
Independent Research: We do not accept payment for rankings or favorable reviews
Affiliate Disclosure: We may earn commissions from qualifying purchases at no extra cost to you
Regular Updates: Content is reviewed and updated monthly for accuracy
Licensed Providers Only: All listed services employ US-licensed healthcare providers
Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.
Independent ResearchNo paid placements
Fact-Checked InformationVerified against official sources
Regularly UpdatedLast updated August 19, 2026
Licensed Providers OnlyAll listed services are US-licensed
Ivim Health In-Depth Review
Written by Eric GoldEditor-in-Chief
13 min readUpdated August 19, 2026
iVIM Health competes on price in the most price-sensitive segment of telehealth: compounded GLP-1 medications. Semaglutide starts at $149/month and tirzepatide at $199/month - both with licensed provider consultation and ongoing clinical support included rather than sold as add-ons. As GLP-1 pricing has compressed across the telehealth market, iVIM has held a position at the lower end without sacrificing the clinical structure that distinguishes medically supervised programs from unregulated online pharmacies. For patients who have made the decision to pursue GLP-1 therapy and are focused on finding the lowest responsible price, iVIM is consistently one of the top options to evaluate.
Pricing: How iVIM Competes on Cost
iVIM Health bills weight loss in two separate line items, and you pay both. Compounded semaglutide starts at $75/month and compounded tirzepatide starts at $133/month, and on top of whichever medication you are prescribed there is a $74.99/month program fee charged separately. Added together that is $149.99/month on the semaglutide path and $207.99/month on the tirzepatide path. Both medication figures are starting prices published on iVIM's own weight loss page, price-verified September 17, 2026, and not a full price list for every dose.
The second thing to settle before you enroll is the commitment. You pick your plan length at checkout, choosing between 1, 2, 4 and 6 months, and iVIM's page says most starts are the 4-month Jumpstart option. Once a plan begins you cannot cancel out of it. At the starting semaglutide price that makes a Jumpstart about $600 you are committed to, medication plus program fee, so read the $75 as the opening figure on a four-month bill rather than a single month you can walk away from.
Tirzepatide at iVIM is a compounded formulation containing the active ingredient in Zepbound and Mounjaro, and a compounded version is not FDA-approved, meaning the FDA has not reviewed that specific preparation for safety, effectiveness or quality. It starts at $133/month, price-verified September 17, 2026, and the $74.99/month program fee applies on top of it exactly as it does on the semaglutide path. We have no verified figure for what other platforms charge for compounded tirzepatide, so compare medication price and program or membership fee side by side rather than trusting one headline number.
Split billing is the part that makes cross-platform comparison go wrong. A platform quoting one all-in monthly figure and a platform quoting $75 plus a separate fee can land in the same place, so the number worth comparing is the total you will actually be billed each month with every fee included. iVIM publishes starting prices rather than a full dose-by-dose list, so confirm the price of the dose you expect to be on, and the current program fee, directly with iVIM before you commit to a plan length.
Ready to Start With Ivim Health?
1
What You Get
Available in all 50 U.S. states
Proprietary GLP-1 ID precision dosing with weekly adjustments
Unlimited provider visits and coaching included
Weight loss medications starting at $75/month + $74.99 membership
The compounded semaglutide and tirzepatide iVIM provides are sourced from FDA-registered 503B outsourcing facilities. This is the critical quality assurance piece for injectable compounded medications and should be verified for any platform you consider.
503B facilities are registered with the FDA, subject to unannounced FDA inspections, and must follow Current Good Manufacturing Practice (cGMP) standards for sterility, potency, and contamination. They are not the same as 503A patient-specific compounding pharmacies, which have less regulatory oversight. For subcutaneous injectable medications - which carry infection risk if sterility is compromised - 503B sourcing is the appropriate standard.
iVIM's medication is shipped in pre-filled injection pens with the dose pre-set for the appropriate weekly injection. The injection pen simplifies the process for patients new to self-injection - there is no drawing medication into a syringe, no visual estimation of dose, and the auto-injection mechanism reduces needle anxiety.
Vials requiring self-draw with an insulin syringe are used by some platforms and by some patients who prefer them; pens are generally more user-friendly for first-time GLP-1 users. iVIM's use of pen delivery is a practical advantage for patients who are new to injectable medications.
The Enrollment and Titration Process
Enrollment with iVIM begins with an online intake that covers the standard GLP-1 eligibility criteria: BMI, weight history, current medications, cardiovascular history, and contraindications (medullary thyroid cancer history, pancreatitis history, pregnancy). Provider review typically occurs within 24-48 hours.
Once approved, the standard semaglutide titration schedule starts at 0.25mg weekly for the first 4 weeks, increasing to 0.5mg at week 5, 1mg at approximately week 13, with further increases to 1.7mg and 2.4mg (maintenance) at approximately 4-8 week intervals based on tolerance and response. The titration schedule reduces the frequency and severity of GI side effects by allowing gradual physiological adaptation.
iVIM's monthly check-in structure aligns with dosing decisions: each check-in evaluates whether you are tolerating the current dose and whether you are ready to escalate or should stay at the current level longer. Some patients take longer than average to progress through the titration - particularly patients with GI sensitivity - and the monthly check-in protocol allows individualized pacing.
First medications arrive within 5-7 business days after approval. Subsequent shipments are automatic on a monthly cycle. The platform provides injection training materials (video guides and written instructions) to ensure first-time users are comfortable with self-administration before their first injection.
Managing Side Effects on iVIM
GLP-1 medication side effects follow a predictable pattern: nausea, vomiting, diarrhea, and constipation are most common during dose increases and typically diminish as the body adjusts to each new dose level. The incidence of nausea is approximately 40% during the titration phase and decreases considerably at maintenance doses.
iVIM provides 24/7 messaging support through the platform for side effect questions between check-ins. This matters because side effects frequently occur outside business hours and patients benefit from real-time guidance on whether what they are experiencing is normal, whether to try dose reduction strategies, or whether to contact emergency care.
Practical side effect management guidance iVIM provides: eating smaller, lower-fat meals with higher protein content reduces nausea (high-fat meals considerably slow gastric emptying and worsen GLP-1-related nausea); staying well-hydrated prevents dehydration during episodes of vomiting or diarrhea; avoiding eating immediately before sleep reduces nighttime nausea.
For patients with severe nausea that is not resolving with dietary adjustments, iVIM providers can prescribe antiemetics (ondansetron, promethazine) to make the titration phase tolerable. Nausea-driven discontinuation is the most common reason patients stop GLP-1 treatment prematurely, and effective management of this side effect is a significant clinical outcome variable.
Who iVIM Is Best For
iVIM Health is best positioned for patients who have the following profile: meet clinical criteria for GLP-1 treatment (BMI 30+ or BMI 27+ with comorbidity), are comfortable with the self-injection process (or willing to learn), do not have complex metabolic conditions requiring intensive clinical monitoring, and want competitive pricing as a priority in their platform selection.
The platform is not ideal for: patients with diabetes or complex metabolic conditions requiring integrated lab monitoring and coordination with a diabetologist or endocrinologist; patients who want intensive behavioral support (weekly dietitian appointments, structured fitness coaching, CBT for eating behavior); or patients with very severe obesity where in-person bariatric medicine offers substantially better clinical outcomes than compounded GLP-1 alone.
For the cost-conscious patient who qualifies for GLP-1 treatment and wants a straightforward, medically supervised program at a competitive price, iVIM delivers that efficiently. The lower price point does not mean inadequate care when the clinical oversight fundamentals are present - and at iVIM, the monthly check-in structure, 503B sourcing, and 24/7 messaging support represent those fundamentals.
The critical caveat applies to all compounded GLP-1 platforms: the regulatory status of compounded semaglutide and tirzepatide is subject to FDA oversight and has been a source of regulatory attention as the market has grown rapidly. Patients on compounded GLP-1 programs should monitor for regulatory changes that could affect medication availability.
iVIM's clinical approach follows that consensus: GLP-1 treatment is generally a long-term therapy rather than a temporary intervention. The appetite reduction is an effect of the drug being present rather than a permanent change to how your hunger signalling works, so when you stop the medication the drivers it was suppressing tend to return. Whether any of that applies to you is a question for the prescriber who reviews your history, not something to settle from a pricing page.
That has a practical implication for what you budget. iVIM's semaglutide path is $75/month for the medication plus the separate $74.99/month program fee, which is $149.99/month when you add the two, price-verified September 17, 2026. Those are starting figures, and iVIM does not publish what a higher maintenance dose costs. A starting price multiplied out into an annual or five-year total is an invented number rather than a quoted one, so budget from the figure iVIM quotes you and re-check it every time your dose changes.
iVIM's monthly check-ins include discussion of long-term strategy at appropriate intervals - when to consider dose reduction, how to identify the lowest effective maintenance dose, and how to build behavioral habits that may eventually support dose reduction or discontinuation.
iVIM vs. Competing GLP-1 Platforms
What separates iVIM from comparable platforms (Eden, Skinny RX, Shed, others in the competitive-pricing tier) is how it structures the price alongside clinical oversight. iVIM splits your bill into a medication price from $75/month and a separate $74.99/month program fee, on a plan length you choose at checkout and cannot cancel out of, so the figure to carry into any comparison is the monthly total and the length of the commitment behind it. Beyond price, what differs between platforms is the support structure: how often you speak with a provider, how reachable support is between scheduled check-ins, and how well the platform manages the titration process.
Against the higher-priced platform Ro Body, iVIM offers meaningfully lower cost at the expense of depth of support. Ro Body includes monthly nutrition counseling with a dietitian as a program component - a service that has real clinical evidence supporting better long-term outcomes. This is a genuine incremental service that the higher price supports.
Your choice comes down to priorities: maximize clinical support and accept the higher cost with Ro Body, or optimize for cost with adequate oversight at iVIM, Eden or a comparable platform. Neither is objectively wrong, and which one fits depends on how much support you actually need and will use.
If you are self-directed, comfortable managing your own nutrition, and mainly want affordable access to the medication with basic clinical oversight, iVIM delivers that at $75/month for the medication plus the $74.99/month program fee. If you expect to need more guidance, particularly for navigating side effects or dietary adaptation, paying more for a support-intensive platform is often worthwhile.
Ready to Start With Ivim Health?
1
What You Get
Available in all 50 U.S. states
Proprietary GLP-1 ID precision dosing with weekly adjustments
Unlimited provider visits and coaching included
Weight loss medications starting at $75/month + $74.99 membership
How much does iVIM Health semaglutide cost per month?
iVIM bills two line items: compounded semaglutide from $75 per month for the medication plus a $74.99 per month program fee, which adds up to $149.99 per month at the starting dose, price-verified September 17, 2026 on iVIM's weight loss page. iVIM's own page says medication cost varies with your treatment plan and does not publish what a higher dose costs, so the quote after your provider evaluation is the real number.
What is included in iVIM Health's monthly subscription?
The subscription includes the compounded medication, monthly provider check-ins, 24/7 messaging support for side effect questions, nutritional guidance, and shipping. No additional consultation fee is charged.
How does iVIM Health ensure medication quality?
iVIM sources from FDA-registered 503B outsourcing facilities that meet current Good Manufacturing Practice standards. Injectable medications from 503B facilities are subject to sterility, potency, and contamination testing.
Does iVIM Health accept insurance?
No. iVIM operates on a cash-pay model. Compounded medications are not covered by insurance. You pay two line items each month, the medication price and the separate $74.99 program fee, rather than one all-in fee.
Who qualifies for iVIM Health GLP-1 treatment?
Adults with BMI 30 or higher, or BMI 27 or higher with a weight-related comorbidity (hypertension, type 2 diabetes, high cholesterol, sleep apnea). People with a history of medullary thyroid cancer, pancreatitis, or pregnancy do not qualify.
How often do I meet with a provider at iVIM?
Monthly check-ins with a provider are included in the subscription. Between check-ins, 24/7 messaging support is available for side effect questions and clinical concerns.
What delivery format does iVIM use for semaglutide?
iVIM ships pre-filled injection pens, which pre-set the dose and simplify the self-injection process. No drawing medication into a syringe is required.
How quickly does medication arrive after enrollment?
Initial shipments arrive within 5-7 business days after provider approval. Approval typically occurs within 24-48 hours of completing the intake form.
Can I get tirzepatide instead of semaglutide through iVIM?
Yes. Compounded tirzepatide starts at $133 per month for the medication plus the same $74.99 per month program fee, which adds up to $207.99 per month at the starting dose, price-verified September 17, 2026. iVIM does not publish what a higher dose costs. Your provider recommends the medication based on your health history and preferences.
What are iVIM Health's most common side effects?
GLP-1 medications commonly cause nausea, vomiting, diarrhea, constipation, and fatigue, particularly during dose increases. These typically improve within 2-3 weeks of each dose change. iVIM providers can prescribe antiemetics if nausea is severe.
Can I cancel my iVIM subscription at any time?
No. iVIM's own weight loss page says its GLP-1 programs are structured around the plan length you pick at checkout, 1, 2, 4 or 6 months, and that cancellation is not available once your program has started. Confirm the current terms with iVIM before you commit to a plan length.
How does iVIM pricing compare to Wegovy or Ozempic?
iVIM's compounded semaglutide is $75 per month for the medication plus a $74.99 per month program fee at the starting dose, price-verified September 17, 2026, and iVIM does not publish what higher doses cost. Wegovy and Ozempic are brand-name products, and what you would pay for them depends on your insurance and where you fill the prescription, so compare the quote iVIM gives you against a real brand-name quote rather than a headline. Compounded versions are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.
Sources & References
Our comparisons are informed by official sources and regulatory guidelines. We encourage you to verify information with authoritative sources.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
Is Ivim Health Legit?
We checked their medical licenses and pharmacy certifications.
Regulatory noticeRegulatory note (verified August 22, 2026): Ivim Services LLC received FDA warning letter MARCS-CMS 721816 on February 20, 2026, after the agency reviewed ivimhealth.com in December 2025. This letter is narrower than most in the same enforcement round: it quotes no marketing claims at all. The one cited violation concerns labeling. Compounded semaglutide and tirzepatide products pictured on the site show the "Ivim" name, which the FDA said represents Ivim as the compounder when it is not, citing 21 CFR 201.1(h)(2) and the misbranding provisions at FD&C Act 502(a) and 502(bb). We checked FDA’s index for a close-out letter and found none; on the public record the matter remains open. Read the FDA letter
Compare Ivim Health to Alternatives
See how Ivim Health stacks up against other popular telehealth providers. Compare pricing, services, and our editorial ratings to find the best option for your needs.
Eric Gold is a writer and editor with a background in digital media and consumer research. He has spent the last several years covering the health and wellness industry, with a particular focus on telehealth services and direct-to-consumer healthcare. Eric believes that access to clear, unbiased information should not require a medical degree. When he is not reviewing telehealth platforms, he enjoys hiking, cooking, and following the stock market a little too closely.
Medical Disclaimer: This review is for informational purposes only and is not a substitute for professional medical advice. Always consult with a licensed healthcare provider before starting any treatment. Individual results may vary. We may receive compensation through affiliate links, which helps support our research and content.
